Showing 1 posts of 1 posts found.
Promatix Biosciences has secured funding through Innovate UK’s Biomedical Catalyst programme to support preclinical development of its lead bispecific antibody-drug …
ProBioGen secures extended GMP authorisation for viral manufacturing facility
PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework